AU3376297A - Human thyrotropin receptor compositions and use thereof - Google Patents
Human thyrotropin receptor compositions and use thereofInfo
- Publication number
- AU3376297A AU3376297A AU33762/97A AU3376297A AU3376297A AU 3376297 A AU3376297 A AU 3376297A AU 33762/97 A AU33762/97 A AU 33762/97A AU 3376297 A AU3376297 A AU 3376297A AU 3376297 A AU3376297 A AU 3376297A
- Authority
- AU
- Australia
- Prior art keywords
- thyrotropin receptor
- receptor compositions
- human thyrotropin
- compositions
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1917196P | 1996-06-05 | 1996-06-05 | |
US60019171 | 1996-06-05 | ||
PCT/US1997/009624 WO1997046206A2 (fr) | 1996-06-05 | 1997-06-05 | Compositions a base de recepteur de la thyrotropine humaine |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3376297A true AU3376297A (en) | 1998-01-05 |
Family
ID=21791804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU33762/97A Abandoned AU3376297A (en) | 1996-06-05 | 1997-06-05 | Human thyrotropin receptor compositions and use thereof |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0959896B1 (fr) |
JP (1) | JP2000512280A (fr) |
AT (1) | ATE510552T1 (fr) |
AU (1) | AU3376297A (fr) |
CA (1) | CA2258720A1 (fr) |
WO (1) | WO1997046206A2 (fr) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
JP4713798B2 (ja) | 1999-06-29 | 2011-06-29 | マンカインド コーポレイション | ペプチドおよびタンパク質の薬学的因子の精製および安定化 |
WO2002034042A2 (fr) * | 2000-10-26 | 2002-05-02 | Deltagen, Inc. | Souris transgeniques contenant des disruptions geniques du recepteur de l'hormone de stimulation thyroidienne (tch-r) |
ES2300568T3 (es) | 2002-03-20 | 2008-06-16 | Mannkind Corporation | Aparato de inhalacion. |
MX2007001903A (es) | 2004-08-20 | 2007-08-02 | Mannkind Corp | Catalisis de sintesis de dicetopiperazina. |
DK1791542T3 (en) | 2004-08-23 | 2015-06-15 | Mannkind Corp | Diketopiperazinsalte for pharmaceutical delivery |
CA2621806C (fr) | 2005-09-14 | 2016-08-02 | Mannkind Corporation | Procede de preparation de medicaments fonde sur l'accroissement de l'affinite des surfaces de microparticules cristallines pour des principes actifs |
CN101389348A (zh) | 2006-02-22 | 2009-03-18 | 曼金德公司 | 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法 |
EP3281663B8 (fr) | 2008-06-13 | 2022-09-21 | MannKind Corporation | Inhalateur de poudre sèche alimenté par la respiration pour l'administration de médicaments |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
ES2421385T3 (es) | 2008-06-20 | 2013-09-02 | Mannkind Corp | Aparato interactivo y procedimiento para establecer el perfil, en tiempo real, de esfuerzos de inhalación |
TWI532497B (zh) | 2008-08-11 | 2016-05-11 | 曼凱公司 | 超快起作用胰島素之用途 |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
WO2010105094A1 (fr) | 2009-03-11 | 2010-09-16 | Mannkind Corporation | Appareil, système et procédé de mesure de résistance d'un inhalateur |
ES2943333T3 (es) | 2009-06-12 | 2023-06-12 | Mannkind Corp | Micropartículas de dicetopiperazina con superficies específicas definidas |
EP2496295A1 (fr) | 2009-11-03 | 2012-09-12 | MannKind Corporation | Appareil et méthode de simulation d'efforts d'inhalation |
CA2801936C (fr) | 2010-06-21 | 2021-06-01 | Mannkind Corporation | Systeme et procede d'administration de medicament sous la forme d'une poudre seche |
CN105667994B (zh) | 2011-04-01 | 2018-04-06 | 曼金德公司 | 用于药物药盒的泡罩包装 |
WO2012174472A1 (fr) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | Microparticules de dicétopipérazine de capacité élevée |
KR20140095483A (ko) | 2011-10-24 | 2014-08-01 | 맨카인드 코포레이션 | 통증을 치료하기 위한 방법 및 조성물 |
CN104619369B (zh) | 2012-07-12 | 2018-01-30 | 曼金德公司 | 干粉药物输送系统和方法 |
WO2014066856A1 (fr) | 2012-10-26 | 2014-05-01 | Mannkind Corporation | Compositions et procédés de vaccin antigrippal inhalable |
US10421729B2 (en) | 2013-03-15 | 2019-09-24 | Mannkind Corporation | Microcrystalline diketopiperazine compositions and methods |
ES2747634T3 (es) | 2013-05-14 | 2020-03-11 | Siemens Healthcare Diagnostics Inc | Formulaciones líquidas estabilizadas que contienen receptores |
CN114848614A (zh) | 2013-07-18 | 2022-08-05 | 曼金德公司 | 热稳定性干粉药物组合物和方法 |
CA2920488C (fr) | 2013-08-05 | 2022-04-26 | Mannkind Corporation | Appareil d'insufflation et procedes |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0557273A1 (fr) * | 1990-11-15 | 1993-09-01 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Gene de rat recepteur de thyrotropine et utilisation dudit gene |
-
1997
- 1997-06-05 CA CA002258720A patent/CA2258720A1/fr not_active Abandoned
- 1997-06-05 EP EP97929783A patent/EP0959896B1/fr not_active Expired - Lifetime
- 1997-06-05 JP JP10500809A patent/JP2000512280A/ja not_active Ceased
- 1997-06-05 WO PCT/US1997/009624 patent/WO1997046206A2/fr active Application Filing
- 1997-06-05 AU AU33762/97A patent/AU3376297A/en not_active Abandoned
- 1997-06-05 AT AT97929783T patent/ATE510552T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO1997046206A2 (fr) | 1997-12-11 |
EP0959896B1 (fr) | 2011-05-25 |
EP0959896A2 (fr) | 1999-12-01 |
JP2000512280A (ja) | 2000-09-19 |
EP0959896A4 (fr) | 2005-03-02 |
ATE510552T1 (de) | 2011-06-15 |
CA2258720A1 (fr) | 1997-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3376297A (en) | Human thyrotropin receptor compositions and use thereof | |
IL128003A0 (en) | Therapeutic multispecific compounds comprised of anti-fcalpha receptor antibodies | |
MX9803992A (es) | Metodos para incrementar la masa de tejido muscular usando composiciones de la proteina ob. | |
AU4230493A (en) | Diphtheria toxin receptor-binding region | |
YU20600A (sh) | Nova upotreba antagonista 5-ht3 receptora | |
MXPA05014152A (es) | Anticuerpos dirigidos a los mutantes de delecion de receptor de factor de crecimiento epidermico y sus usos. | |
NZ324500A (en) | Humanized antibodies to human gp39, compositions containing and therapeutic use thereof | |
CA2310888A1 (fr) | Anticorps monoclonaux naturels humains | |
AU5624699A (en) | Use of 5ht-6 antagonists | |
AU3508497A (en) | Androgen receptor modulator compounds and methods | |
AU4072397A (en) | Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor | |
AU4622297A (en) | Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr) | |
EP1382597A3 (fr) | Composés modulateurs des récepteurs des stéroides et procédés d'utilisations | |
GB9317104D0 (en) | Therapeutic heterocycles | |
AU5186799A (en) | Peptides of il-2 and derivatives thereof and their use as therapeutic agents | |
AU2649597A (en) | Non-invasive real time diagnosis of migraine | |
AU2990695A (en) | Mucin-derived proteins for the diagnosis, imaging, and therapy of human cancer | |
AU5369996A (en) | Monoclonal antibody against human receptor protein 4-1bb and methods of its use for treatment of diseases | |
HK1025500A1 (en) | Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases | |
AU5506896A (en) | Human p2x4 receptor splice-variants | |
AU9363398A (en) | Hepatitis c receptor protein cd81 | |
AU3745795A (en) | Use of CCK-B receptor antagonists for the treatment of sleepdisorders | |
IL131478A0 (en) | Methods for treatment of scar tissue | |
EP1039931A4 (fr) | Anticorps de recombinaison multivalents destines au traitement d'infections dues au rhinovirus humain (hrv) | |
AU3416995A (en) | Endothelin receptor antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |